Alerts will be sent to your verified email
Verify Email
ZENITHDRUG
|
Zenith Drugs
|
Sotac Pharmaceutical
|
Murae Organisor
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
22.97 % | -4.85 % | 7.44 % |
|
5yr average Equity Multiplier
|
4.46 | 7.05 | 1.97 |
|
5yr Average Asset Turnover Ratio
|
1.16 | 1.3 | 0.85 |
|
5yr Avg Net Profit Margin
|
4.99 % | 1.45 % | 5.88 % |
|
Price to Book
|
0.0 | 0.0 | 0.63 |
|
P/E
|
13.84 | 31.14 | 17.43 |
|
5yr Avg Cash Conversion Cycle
|
-99.3 Days | 3.3 Days | 3241.06 Days |
|
Inventory Days
|
53.1 Days | 36.47 Days | 515.14 Days |
|
Days Receivable
|
141.66 Days | 72.11 Days | 1372.66 Days |
|
Days Payable
|
298.39 Days | 136.32 Days | 17.5 Days |
|
5yr Average Interest Coverage Ratio
|
4.04 | 3.3 | 11.0 |
|
5yr Avg ROCE
|
30.01 % | 19.17 % | 12.76 % |
|
5yr Avg Operating Profit Margin
|
9.39 % | 7.12 % | -13.99 % |
|
5 yr average Debt to Equity
|
1.14 | 2.81 | 0.48 |
|
5yr CAGR Net Profit
|
25.02 % | 116.49 % | -51.27 % |
|
5yr Average Return on Assets
|
5.56 % | 1.93 % | 4.01 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
69.98 % | 72.85 % | 0.0 |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
0.0 | 0.0 | -50.21 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Zenith Drugs
|
Sotac Pharmaceutical
|
Murae Organisor
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
-
|
|
Distribution Channel
|
Distribution Channel
|
-
|
-
|